PRO*BPD: Effectiveness of outpatient treatment PROgrammes for Borderline Personality Disorder: A comparison of Schema Therapy and Dialectical Behaviour Therapy

Phase 4

Conditions: F60.31

Registration Number: DRKS00011534

Lead Sponsor: Klinik für Psychiatrie und Psychotherapie, Universität zu Lübeck

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 167

Inclusion Criteria

Primary DSM-IV diagnosis of BPD (diagnosed by SCID-II interview)
Severity of BPD > 20 points in the BPDSI interview (this is a empirically derived severity criterion, distinguishing BPD pathology from other PD-pathology)
Willingness to participate in the study (informed consent)
Willingness and ability to remain for 1.5 years in the study and to participate reliably in therapy (no relocation plans etc.)

Exclusion Criteria

Major psychotic disorder (lifetime diagnosis
Intellectual deficits (IQ<85)
Inadequate German language skills
Acute serious substance dependencies (DSM-IV) that cause severe cognitive restrictions during therapy and which calls for detoxification treatment. Participation is possible after detox treatment and a four weeks abstinence period.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in BPD symptom severity assessed with the mean score of the Borderline-Personality Disorder Severity Index at 1 year follow up.

Secondary Outcome Measures

Name	Time	Method
Change in quality of life measured with EQ-5D and WHOQoL, social functioning and participation measured with GAF-SOFAS, Cost-effectiveness measured with a COST-Interview, comorbidity (SKID I and II), general psychiatric symptoms (BSI, QIDS), other measures of BPD-psychopathology (dissociation, emotion regulation skills, experiential avoidance) at one year follow-up.